Author

A. A. Khokhlov

Observed names: A. A Khokhlov, A.A. Khokhlov

Institution: Yaroslavl State Medical Academy

Observed institutions: Russian Academy of Sciences, Yaroslavl State Medical Academy, Russian Railways, Ministry of Health of the Russian Federation, Scientific Research Institute of Healthcare Organization and Medical Management

ORCID: 0000-0002-3307-0705

Observed ORCIDs: 0000-0002-3307-0705, 0000-0002-6684-4199, 0000-0002-0032-0341

OpenAlex ID: A5029510329

Oral anticoagulants in the prevention of thromboembolic complications in cardiac patients: analysis of use in the Russian Federation

2020 · A. A. Gruzdeva, A. A. Khokhlov, et al. · Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice · 6

PDF

Pharmacogenetic Features of Therapy of Patients With Atherosclerosis

2018 · A. L. Khokhlov, A. N. Yavorsky, et al. · The Russian Archives of Internal Medicine · 6

PDF

Pharmacogenetic Aspects of Type 2 Diabetes Treatment

2020 · N. O. Pozdnyakov, I. N. Kagarmanyan, et al. · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук · 2

PDF

Bioequivalence study of fixed-dose combination Losartan + amlodipine + rosuvastatin Sanofi in comparison with coadministered fixed- dose combination Lozap® AM and monocomponent drug Crestor® in healthy subjects

2022 · A. L. Khokhlov, D. Yu. Grebenkin, et al. · Pharmacokinetics and Pharmacodynamics · 1

PDF

Pharmacokinetic and Bioequivalence Study of the Two-component Drug Product "Ezetimibe + rosuvastatin" (JSC "Sanofi-aventis group", Russia): Resuts and Experience with the Use of Enzymatic Hydrolysis in the Analysis of Samples

2023 · A. L. Khokhlov, D. Yu. Grebenkin, et al. · Drug development & registration

PDF

Pharmacokinetic and bioequivalence study of Telzap® Plus fixed-dose combination compared with MikardisPlus® in healthy volunteers after single administration

2023 · A. L. Khokhlov, A. A. Khokhlov, et al. · Pharmacokinetics and Pharmacodynamics

PDF

Pharmacokinetic and bioequivalence study of Telzap® in comparison with Mikardis® in healthy subjects after single administrationl

2023 · A. L. Khokhlov, A. A. Khokhlov, et al. · Pharmacokinetics and Pharmacodynamics

PDF

Evaluation of clinical outcomes of COVID-19 in patients taking remdesivir in complex therapy in routine clinical practice

2022 · M.V. Zhuravleva, E.V. Kuznetsova, et al. · Infectious diseases News Opinions Training

PDF

Pharmacokinetic and Bioequivalence Study of Telzap AM® (Telmisartan/amlodipine Fixed-dose Combination) and Coadministered Mikardis® (Telmisartan) and Norvask® (Amlodipine) in Healthy Subjects

2020 · V. Kubesh, A. L. Khokhlov, et al. · Drug development & registration

PDF

Study of Comparative Pharmacokinetics and Bioequivalence of Drugs Amlodipine + Valsartan and Exforge®

2018 · A. L Khokhlov, A. E Miroshnikov, et al. · Russian Medicine

Works count: 10

Citation count: 15

H-index: 2

I10-index: